Table 5

Associations between genetically predicted serum total bilirubin and lung cancer incidence by smoking status in white British unrelated participants of UK Biobank

IRR per 5 μmol/L increase (95% CI) *P valueEstimated incidence change in 10,000PYs per 5 μmol/L increase (95% CI) *
Overall0.90 (0.83 to 0.99)0.023−0.76 (−1.42 to −0.10)
Never smokers0.98 (0.78 to 1.22)0.87−0.04 (−0.49 to 0.41)
Former smokers0.95 (0.84 to 1.08)0.40−0.47 (−1.57 to 0.63)
Current smokers0.83 (0.72 to 0.96)0.011−6.44 (−11.45 to −1.44)
Regular smokers (cigarettes per day)
 Overall†0.89 (0.80 to 0.99)0.028−2.08 (−4.00 to −0.16)
 Former 1–191.04 (0.81 to 1.33)0.740.31 (−1.57 to 2.20)
 Former ≥200.92 (0.79 to 1.08)0.29−1.38 (−3.94 to 1.18)
 Current 1–190.94 (0.76 to 1.17)0.57−2.19 (−9.79 to 5.42)
 Current ≥200.72 (0.58 to 0.90)0.0037−23.13 (−38.93 to −7.32)
  • *Adjusted for age, gender, calendar year, ethnicity (first 40 principal components), recruitment centre and smoking status. Adjusted and unadjusted incidence rate ratios are reported in online supplementary table S1.

  • †Adjusted for pack-years, age, gender, calendar year, ethnicity (first 40 principal components), recruitment centre in overall analysis of regular smokers.

  • IRR, incidence rate ratio.